Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

6.48
Delayed Data
As of May 27
 +0.20 / +3.18%
Today’s Change
6.03
Today|||52-Week Range
12.88
-30.99%
Year-to-Date

Today’s Trading

Previous close6.28
Today’s open6.32
Day’s range-- - --
Volume1,056,218
Average volume (3 months)1,241,642
Market cap$273.4M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-34.41%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...+0.04+1.03%
VTAEVitae Pharmaceutical...+0.14+1.14%
TRVNTrevena Inc+0.41+6.06%
AMBIAmbit Biosciences Co...----
Data as of 05/27/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers